Cargando…
Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial
BACKGROUND: The treatment for ineligible transplant multiple myeloma is melphalan prednisone. Curcumin has an anti-inflammatory and antiangiogenesis in cancer-directed to nuclear factor-kappa B (NF-kB) pathway. Interleukin 6 (IL-6), vascular endothelial growth factor (VEGF), tumor necrosis factor-al...
Autores principales: | Santosa, Damai, Suharti, Catharina, Riwanto, Ignatius, Dharmana, Edi, Pangarsa, Eko Adhi, Setiawan, Budi, Suyono, Suyono, Tobing, Mika Lumban, Suhartono, Suhartono, Hadisapurto, Soeharyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301229/ https://www.ncbi.nlm.nih.gov/pubmed/35919637 http://dx.doi.org/10.22088/cjim.13.2.9 |
Ejemplares similares
-
Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020) -
Clinical Evaluation for the Role of High-Sensitivity C-Reactive Protein in Combination with D-Dimer and Wells Score Probability Test to Predict the Incidence of Deep Vein Thrombosis Among Cancer Patients
por: Setiawan, Budi, et al.
Publicado: (2020) -
The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy: A randomised controlled trial: open label
por: Setiawan, Budi, et al.
Publicado: (2023) -
The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin's Lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2021) -
Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis
por: Setiawan, Budi, et al.
Publicado: (2022)